Monitor for early lock-up waiver filings or 10b5-1 plan adoption by the selling securityholders, particularly the two Centerbridge-managed entities holding 12.5 million shares each. The first 25% tranche of shares becomes eligible for sale 12 months post-closing (October 2027). The Nasdaq non-compliance issue adds delisting risk if not cured by September 2027.
Price Chart
Executive Summary
SKYX Platforms Corp. filed an S-3 registration statement to register 25,250,000 shares of common stock for resale by selling securityholders (Massachusetts Mutual Life Insurance, MassMutual Ascend Life Insurance, and Needham & Company) issued in connection with the recently closed Deako merger. The company will not receive any proceeds from the resale. The shares represent approximately 18.28% of total shares outstanding pre-merger, creating significant overhang risk, though they are subject to a 21-month staggered lock-up.
Key Financial Metrics
Key Facts
- Registers 25,250,000 shares for resale by selling securityholders from the Deako merger
- Shares represent approximately 18.28% of total shares outstanding as of October 12, 2026, prior to the merger
- Company will not receive any proceeds from the resale
- Lock-up restrictions expire in four equal tranches at 12, 15, 18, and 21 months after the October 13, 2026 closing date
- Closing stock price on October 13, 2026 was $1.12 per share
- Maximum aggregate offering price calculated at $28,532,500 for filing fee purposes
- Company is not in compliance with Nasdaq board independence and audit committee composition requirements following the death of an independent director, with a cure period expiring by September 26, 2027
Financial Impact
Potential overhang of up to 25,250,000 shares (~18.28% of pre-merger outstanding shares) at $1.12/share, representing approximately $28.3 million in potential selling pressure, subject to staggered lock-up
Risk Factors
- Significant overhang from potential resale of 25.25 million shares (~18.28% of pre-merger outstanding)
- Nasdaq delisting risk due to board independence and audit committee composition non-compliance
- Integration risk from the Deako merger, which closed on October 13, 2026
- Low stock price ($1.12) increases sensitivity to selling pressure
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001493152-26-047035 |
| Exhibit: ex107.htm | 0001493152-26-047035 |
| Exhibit: ex5-1.htm | 0001493152-26-047035 |
| Exhibit: ex23-1.htm | 0001493152-26-047035 |
| Document: 0001493152-26-047035-index-headers.html | 0001493152-26-047035 |
| Document: 0001493152-26-047035-index.html | 0001493152-26-047035 |
| Document: 0001493152-26-047035.txt | 0001493152-26-047035 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | EFFECT | $0.9000 | awaiting T+60 | — | $0.7920 (+12.00%) |
Oct 14, 2026 13d ago | S-3 | $1.01 | awaiting T+60 | — | $0.7920 (+21.58%) |
Oct 14, 2026 13d ago | 8-K | $1.04 | awaiting T+60 | — | $0.7920 (−23.85%) |
Oct 1, 2026 26d ago | 8-K | $1.18 | awaiting T+60 | — | $0.7920 (+32.88%) |
Sep 10, 2026 6w ago | 8-K | $1.32 | awaiting T+60 | — | $0.7920 (−40.00%) |
Sep 10, 2026 6w ago | Press Release | $1.32 | awaiting T+60 | — | $0.7920 (−40.00%) |
May 13, 2026 23w ago | DEFA14A | $1.14 $1.22 | ▲ +7.02% | ▲ +3.43% | $0.7920 (−30.53%) |
May 11, 2026 24w ago | 8-K | $1.14 $1.19 | ▲ +4.85% | ▲ +0.46% | $0.7920 (−30.22%) |
May 11, 2026 24w ago | Press Release | $1.14 $1.19 | ▲ +4.85% | ▲ +0.46% | $0.7920 (−30.22%) |
May 7, 2026 24w ago | Press Release | $1.46 $1.11 | ▼ −23.97% | ▼ −27.81% | $0.7920 (−45.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers